Detalhe da pesquisa
1.
Nomogram for predicting survival in patients with advanced hepatocellular carcinoma treated with PD-1 inhibitors: incorporating pre-treatment and post-treatment clinical parameters.
BMC Cancer
; 23(1): 556, 2023 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328805
2.
Nomograms Predict PFS and OS for SCLC Patients After Standardized Treatment: A Real-World Study.
Int J Gen Med
; 17: 1949-1965, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736664
3.
A multicenter, real-world study on effectiveness and safety of first-line modified PD-1 inhibitors with chemotherapy in advanced non-small cell lung cancer (aNSCLC) with drive gene-negative.
Cancer Med
; 13(3): e7024, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400661
4.
Clinical Significance and Immune Infiltration Analyses of a Novel Nerve-Related lncRNA Signature in Gastric Cancer.
Mol Biotechnol
; 2023 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145446
5.
Sirolimus can promote the disappearance of renal angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study.
World J Pediatr
; 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773307
6.
Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis.
Front Oncol
; 12: 974227, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523994
7.
Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients.
Medicine (Baltimore)
; 99(24): e20545, 2020 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32541476